BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34725726)

  • 1. Hot needles can confirm accurate lesion sampling intraoperatively using [
    Ferraro DA; Laudicella R; Zeimpekis K; Mebert I; Müller J; Maurer A; Grünig H; Donati O; Sapienza MT; Rueschoff JH; Rupp N; Eberli D; Burger IA
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1721-1730. PubMed ID: 34725726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of
    Ferraro DA; Becker AS; Kranzbühler B; Mebert I; Baltensperger A; Zeimpekis KG; Grünig H; Messerli M; Rupp NJ; Rueschoff JH; Mortezavi A; Donati OF; Sapienza MT; Eberli D; Burger IA
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3315-3324. PubMed ID: 33620559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and prospective validation of an SUV
    Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W
    Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating the value of
    Luo L; Zheng A; Chang R; Li Y; Gao J; Wang Z; Duan X
    Cancer Imaging; 2023 Nov; 23(1):108. PubMed ID: 37924154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Evaluation of
    Lopci E; Lughezzani G; Castello A; Saita A; Colombo P; Hurle R; Peschechera R; Benetti A; Zandegiacomo S; Pasini L; Casale P; Pietro D; Bevilacqua G; Balzarini L; Buffi NM; Guazzoni G; Lazzeri M
    Eur Urol Focus; 2021 Jul; 7(4):764-771. PubMed ID: 32312701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of malignancy and PSMA expression of uncertain bone foci in [
    Vollnberg B; Alberts I; Genitsch V; Rominger A; Afshar-Oromieh A
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3910-3916. PubMed ID: 35482114
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Liu C; Liu T; Zhang Z; Zhang N; Du P; Yang Y; Liu Y; Yu W; Li N; Gorin MA; Rowe SP; Zhu H; Yan K; Yang Z
    J Nucl Med; 2020 Sep; 61(9):1314-1319. PubMed ID: 32034111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head-to-Head Comparison of
    Kuten J; Fahoum I; Savin Z; Shamni O; Gitstein G; Hershkovitz D; Mabjeesh NJ; Yossepowitch O; Mishani E; Even-Sapir E
    J Nucl Med; 2020 Apr; 61(4):527-532. PubMed ID: 31562225
    [No Abstract]   [Full Text] [Related]  

  • 11. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT).
    Heetman JG; Lavalaye J; Polm PD; Soeterik TFW; Wever L; Paulino Pereira LJ; van der Hoeven EJRJ; van Melick HHE; van den Bergh RCN
    Eur Urol Oncol; 2024 Apr; 7(2):204-210. PubMed ID: 37296065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Diagnostic Yield of
    Kumar R; Singh SK; Mittal BR; Vadi SK; Kakkar N; Singh H; Krishnaraju VS; Kumar S; Bhattacharya A
    Radiology; 2022 May; 303(2):392-398. PubMed ID: 35191735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.
    Bodar YJL; Boevé LMS; van Leeuwen PJ; Baars PC; Nieuwenhuijzen JA; van Haarst EP; Oddens JR; Donswijk ML; van Riel LAMJG; Scheltema MJ; Meijer D; Hendrikse NH; Oprea-Lager DE; Vis AN
    BJU Int; 2023 Dec; 132(6):705-712. PubMed ID: 37620288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of prostate cancer with
    Bodar YJL; Jansen BHE; van der Voorn JP; Zwezerijnen GJC; Meijer D; Nieuwenhuijzen JA; Boellaard R; Hendrikse NH; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
    World J Urol; 2021 Jul; 39(7):2439-2446. PubMed ID: 33079250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of
    Liu X; Wang Q; Zhang B; Jiang T; Zeng W
    Hell J Nucl Med; 2022; 25(1):88-102. PubMed ID: 35388806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental Impact of [
    Szigeti F; Schweighofer-Zwink G; Meissnitzer M; Hauser-Kronberger C; Hitzl W; Kunit T; Forstner R; Pirich C; Beheshti M
    Mol Imaging Biol; 2022 Feb; 24(1):50-59. PubMed ID: 34519966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial.
    Krausewitz P; Bundschuh RA; Gaertner FC; Essler M; Attenberger U; Luetkens J; Kristiansen G; Muders M; Ohlmann CH; Hauser S; Ellinger J; Ritter M
    Trials; 2023 Mar; 24(1):167. PubMed ID: 36879271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
    BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    de Jong AC; Smits M; van Riet J; Fütterer JJ; Brabander T; Hamberg P; van Oort IM; de Wit R; Lolkema MP; Mehra N; Segbers M; van der Veldt AAM
    J Nucl Med; 2020 Nov; 61(11):1607-1614. PubMed ID: 32169916
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Pepe P; Pepe L; Tamburo M; Marletta G; Savoca F; Pennisi M; Fraggetta F
    In Vivo; 2023; 37(3):1318-1322. PubMed ID: 37103095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.